Low sun exposure increases multiple sclerosis risk both directly and indirectly.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 08 11 2019
accepted: 12 12 2019
revised: 10 12 2019
pubmed: 18 12 2019
medline: 2 1 2021
entrez: 18 12 2019
Statut: ppublish

Résumé

We aimed to study (1) to what extent the influence of low sun exposure on multiple sclerosis (MS) risk is mediated by low vitamin D levels; (2) whether low sun exposure or vitamin D deficiency act synergistically with HLA-DRB1*15:01 and absence of HLA-A*02:01. We used two population-based case-control studies (7069 cases, 6632 matched controls). Subjects with different HLA alleles, sun exposure habits and vitamin D status were compared regarding MS risk, by calculating odds ratios (OR) with 95% confidence intervals (CI) employing logistic regression. Mediation analysis was used to identify the potential mediation effect of vitamin D on the relationship between low sun exposure and MS risk. Low sun exposure increased MS risk directly as well as indirectly, by affecting vitamin D status. The direct effect, expressed as OR, was 1.26 (95% CI 1.04-1.45) and the indirect effect, mediated by vitamin D deficiency, was 1.10 (95% CI 1.02-1.23). Of the total effect, nearly 30% was mediated by vitamin D deficiency. There was a significant interaction between low sun exposure and vitamin D deficiency (attributable proportion due to interaction 0.3, 95% CI 0.04-0.5) accounting for about 12% of the total effect. Further, both factors interacted with HLA-DRB1*15:01 to increase MS risk. Our findings indicate that low sun exposure acts both directly on MS risk as well as indirectly, by leading to low vitamin D levels. The protective effect of sun exposure thus seems to involve both vitamin D and non-vitamin D pathways, which is of relevance for prevention, in particular for those with a genetic susceptibility to MS.

Identifiants

pubmed: 31844981
doi: 10.1007/s00415-019-09677-3
pii: 10.1007/s00415-019-09677-3
pmc: PMC7109160
doi:

Substances chimiques

HLA-A*02:01 antigen 0
HLA-A2 Antigen 0
HLA-DRB1 Chains 0
HLA-DRB1*15:01 antigen 0
Hydroxycholecalciferols 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1045-1052

Références

Eur J Neurol. 2012 Jul;19(7):955-62
pubmed: 22289117
Neurology. 2019 Dec 10;93(24):e2203-e2215
pubmed: 31690681
Neurodegener Dis Manag. 2015 Oct;5(5):413-24
pubmed: 26477548
Ann Neurol. 2000 Jun;47(6):831-5
pubmed: 10852554
Ann Neurol. 2014 May;75(5):739-58
pubmed: 24771567
Acta Neurol Scand. 2015;132(199):11-9
pubmed: 26046553
Blood. 1990 Jul 1;76(1):189-97
pubmed: 2364169
Acta Neurol Scand. 2015;132(199):56-61
pubmed: 26046560
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6418-23
pubmed: 20308557
Nat Genet. 2015 Oct;47(10):1107-1113
pubmed: 26343388
BMJ. 2016 Feb 25;352:i969
pubmed: 26916049
Nutrients. 2010 May;2(5):482-95
pubmed: 22254036
Nutrients. 2018 Feb 27;10(3):
pubmed: 29495467
Neurology. 2011 Feb 8;76(6):540-8
pubmed: 21300969
Mult Scler. 2013 Sep;19(10):1355-8
pubmed: 23413297
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1193-1200
pubmed: 31217172
Psychol Methods. 2013 Jun;18(2):137-50
pubmed: 23379553
Mult Scler. 2019 Feb;25(2):180-186
pubmed: 30251921
Neurology. 2014 Mar 11;82(10):865-72
pubmed: 24500647
Mult Scler. 2004 Apr;10(2):202-11
pubmed: 15124768
Front Immunol. 2017 Jan 24;8:3
pubmed: 28167940
Arch Biochem Biophys. 2015 Feb 1;567:75-82
pubmed: 25541149
PLoS Genet. 2009 Feb;5(2):e1000369
pubmed: 19197344
Sci Rep. 2015 Dec 11;5:18083
pubmed: 26656273
Neurol Genet. 2016 Sep 13;2(5):e97
pubmed: 27652346
PLoS Comput Biol. 2013;9(2):e1002877
pubmed: 23459081
Med Chem. 2018 Feb 6;14(2):129-143
pubmed: 28933265

Auteurs

Anna Karin Hedström (AK)

Department of Clinical Neuroscience, Karolinska Institutet, 17177, Stockholm, Sweden. anna.hedstrom@ki.se.

Tomas Olsson (T)

Department of Clinical Neuroscience, Karolinska Institutet, 17177, Stockholm, Sweden.

Ingrid Kockum (I)

Department of Clinical Neuroscience, Karolinska Institutet, 17177, Stockholm, Sweden.

Jan Hillert (J)

Department of Clinical Neuroscience, Karolinska Institutet, 17177, Stockholm, Sweden.

Lars Alfredsson (L)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Occupational and Environmental Medicine, Stockholm County Council, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH